English
This article is from The Journal of Clinical Endocrinology and Metabolism , volume 99 . Abstract Context:: Hashimoto's thyroiditis is less prevalent in tobacco smokers. Anatabine, an alkaloid found in Solanaceae plants including tobacco, has been reported to ameliorate a mouse model of Hashimoto's thyroiditis. Objective:: The effects of anatabine in patients with Hashimoto's thyroiditis were studied. Design, Setting, Patients, and Intervention:: This was a double-blind, randomized, placebo-controlled multisite study. A total of 146 patients (70 treated with anatabine and 76 with placebo) completed the study. Approximately 50% of patients in each group were taking levothyroxine. Anatabine lozenges (9–24 mg/d) or placebo, each containing vitamins A and D3, were administered orally 3 times a day for 3 months. Main Outcome Measures:: Serum thyroperoxidase antibody (TPOAb) and thyroglobulin antibody (TgAb) levels were assessed. Safety was assessed through adverse events, clinical laboratory evaluations, and vital sign measurements. Results:: Anatabine-treated patients had a significant reduction in absolute serum TgAb levels from baseline by study end relative to those receiving placebo
Sign in with your free account to read, download EPUBs or listen.
Ebook · Anatabine Supplementation Decreases Thyroglobulin Antibodies in Patients With Chronic Lymphocytic Autoimmune (Hashimoto's) Thyroiditis: A Randomized Controlled Clinical Trial. · Schmeltz, Lowell R., Blevins, Thomas C., Aronoff, Stephen L., Ozer, Kerem, Leffert, Jonathan D., Goldberg, Marc A., Horowitz, Barry S., Bertenshaw, Richard H. · Internet Archive